Founder mutations in BRCA1 and BRCA2 genes
Open Access
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 18 (suppl_6) , vi93-vi98
Abstract
BRCA1 and BRCA2 germline mutations contribute to a significant number of familial and hereditary breast and/or ovarian cancers. The proportion of high-risk families with breast and/or ovarian cancer cases due to mutations in these tumor suppressor genes varies widely among populations. In some population, a wide spectrum of different mutations in both genes are present, whereas in other groups specific mutations in BRCA1 and BRCA2 have been reported with high frequency. Most of these mutations are prevalent in restricted populations as consequence of a founder effect. The comparison of haplotypes between families with the same mutation can distinguish whether high-frequency alleles derive from an older or more recent single mutational event or whether they have arisen independently more than once. Here, we review some of the most well-known and significant examples of founder mutations in BRCA genes found in European and non-European populations. In conclusion, the identification of the ethnic group of families undergoing genetic counseling enables the geneticist and oncologist to make more specific choices, leading to simplify the clinical approach to genetic testing carried out on members of high-risk families. Futhermore, the high frequency of founder mutations, allowing to analyze a large number of cases, might provide accurate information regarding their penetrance.Keywords
This publication has 51 references indexed in Scilit:
- Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patientsInternational Journal of Cancer, 2006
- High frequency of BRCA1 5382insC mutation in Russian breast cancer patientsEuropean Journal of Cancer, 2006
- Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer familiesHuman Genetics, 2005
- BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based studyEuropean Journal of Cancer, 2004
- The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancerEuropean Journal of Cancer, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Genetic epidemiology of BRCA1 mutations in NorwayEuropean Journal of Cancer, 2001
- Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerHuman Mutation, 2001
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerThe American Journal of Human Genetics, 2000
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996